Comparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Disease
Clinical trial NCT07308964 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07308964
- Sponsor
- Sheba Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2028-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.